NL-OMON27478尚未招募不适用
Circulating tumor DNA as a biomarker in perihilar cholangiocarcinoma:a feasibility study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- AMC
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients older than 18 years.
- •-Undergoing explorative laparotomy, diagnostic laparoscopy or percutaneous biopsy.
排除标准
- •-Patients 18 years or younger.
- •-Unfit for laparotomy/ diagnostic laparoscopy/ biopsies or blood analyses in palliative
- •chemotherapy studies.
研究者
相似试验
已完成
不适用
Circulating tumor DNA as a biomarker in perihilar cholangiocarcinoma: a feasibility studybiliary tract cancerperihilar cholangiocarcinoma10019815NL-OMON43203Academisch Medisch Centrum20
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancerC73Malignant neoplasm of thyroid glandDRKS00022441niversitätsklinikum Freiburg75
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with Non-Hodgkin Lymphoma (NHL)C83.3C85Diffuse large B-cell lymphomaOther and unspecified types of non-Hodgkin lymphomaDRKS00024180niversitätsklinikum Freiburg200
招募中
不适用
Circulating Tumour DNA in Stage 1 to 4 Ovarian CancerOvarian cancerACTRN12617001119381Walter and Eliza Hall Institute of Medical Research100
尚未招募
不适用
Circulating Tumour DNA as a Marker of Complete Pathological Response and Long Term Outcome for Locally Advanced Rectal Cancer Treated with Pre-operative ChemoradiotherapyACTRN12612000327886udwig Institute for Cancer Research320